TY - JOUR
T1 - Common-Unique Decomposition Driven Diffusion Model for Contrast-Enhanced Liver MR Images Multi-Phase Interconversion
AU - Xu, Chenchu
AU - Tian, Shijie
AU - Wang, Boyan
AU - Zhang, Jie
AU - Polat, Kemal
AU - Alhudhaif, Adi
AU - Li, Shuo
N1 - Publisher Copyright:
© 2013 IEEE.
PY - 2025
Y1 - 2025
N2 - All three contrast-enhanced (CE) phases (e.g., Arterial, Portal Venous, and Delay) are crucial for diagnosing liver tumors. However, acquiring all three phases is constrained due to contrast agents (CAs) risks, long imaging time, and strict imaging criteria. In this paper, we propose a novel Common-Unique Decomposition Driven Diffusion Model (CUDD-DM), capable of converting any two input phases in three phases into the remaining one, thereby reducing patient wait time, conserving medical resources, and reducing the use of CAs. 1) The Common-Unique Feature Decomposition Module, by utilizing spectral decomposition to capture both common and unique features among different inputs, not only learns correlations in highly similar areas between two input phases but also learns differences in different areas, thereby laying a foundation for the synthesis of remaining phase. 2) The Multi-scale Temporal Reset Gates Module, by bidirectional comparing lesions in current and multiple historical slices, maximizes reliance on previous slices when no lesions and minimizes this reliance when lesions are present, thereby preventing interference between consecutive slices. 3) The Diffusion Model-Driven Lesion Detail Synthesis Module, by employing a continuous and progressive generation process, accurately captures detailed features between data distributions, thereby avoiding the loss of detail caused by traditional methods (e.g., GAN) that overfocus on global distributions. Extensive experiments on a generalized CE liver tumor dataset have demonstrated that our CUDD-DM achieves state-of-the-art performance (improved the SSIM by at least 2.2% (lesions area 5.3%) comparing the seven leading methods). These results demonstrate that CUDD-DM advances CE liver tumor imaging technology.
AB - All three contrast-enhanced (CE) phases (e.g., Arterial, Portal Venous, and Delay) are crucial for diagnosing liver tumors. However, acquiring all three phases is constrained due to contrast agents (CAs) risks, long imaging time, and strict imaging criteria. In this paper, we propose a novel Common-Unique Decomposition Driven Diffusion Model (CUDD-DM), capable of converting any two input phases in three phases into the remaining one, thereby reducing patient wait time, conserving medical resources, and reducing the use of CAs. 1) The Common-Unique Feature Decomposition Module, by utilizing spectral decomposition to capture both common and unique features among different inputs, not only learns correlations in highly similar areas between two input phases but also learns differences in different areas, thereby laying a foundation for the synthesis of remaining phase. 2) The Multi-scale Temporal Reset Gates Module, by bidirectional comparing lesions in current and multiple historical slices, maximizes reliance on previous slices when no lesions and minimizes this reliance when lesions are present, thereby preventing interference between consecutive slices. 3) The Diffusion Model-Driven Lesion Detail Synthesis Module, by employing a continuous and progressive generation process, accurately captures detailed features between data distributions, thereby avoiding the loss of detail caused by traditional methods (e.g., GAN) that overfocus on global distributions. Extensive experiments on a generalized CE liver tumor dataset have demonstrated that our CUDD-DM achieves state-of-the-art performance (improved the SSIM by at least 2.2% (lesions area 5.3%) comparing the seven leading methods). These results demonstrate that CUDD-DM advances CE liver tumor imaging technology.
KW - Contrast-enhanced liver magnetic resonance imaging
KW - feature decomposition
KW - multi-phase interconversion
UR - http://www.scopus.com/inward/record.url?scp=85197523193&partnerID=8YFLogxK
U2 - 10.1109/JBHI.2024.3421254
DO - 10.1109/JBHI.2024.3421254
M3 - Article
C2 - 38959147
AN - SCOPUS:85197523193
SN - 2168-2194
VL - 29
SP - 4633
EP - 4646
JO - IEEE Journal of Biomedical and Health Informatics
JF - IEEE Journal of Biomedical and Health Informatics
IS - 7
ER -